Search Results - "ZSCHABER, R"

Refine Results
  1. 1
  2. 2

    Isolated angiitis of the central nervous system : Lack of inflammation after long-term treatment by RIEMER, G, LAMSZUS, K, ZSCHABER, R, FREITAG, H. J, EGGERS, C, PFEIFFER, G

    Published in Neurology (1999)
    “…A case of isolated angiitis of the CNS was observed for 5 years. Initial response to cyclophosphamide was followed by relapse on therapy interruption. After…”
    Get full text
    Journal Article
  3. 3

    The clinical presentation of non-hodgkin lymphomas of the major salivary glands by JAEHNE, M, USSMÜLLER, J, JÄKEL, K. T, ZSCHABER, R

    Published in Acta oto-laryngologica (01-07-2001)
    “…The aim of this study was to examine the clinical presentation of patients with malignant lymphoma of the major salivary glands. In a retrospective study, 26…”
    Get full text
    Journal Article
  4. 4

    Allogeneic bone marrow transplantation for refractory mantle cell lymphoma by KRÖGER, N, HOFFKNECHT, M, KRÜGER, W, ZELLER, W, RENGES, H, STUTE, N, ZSCHABER, R, ZANDER, A. R

    Published in Annals of hematology (01-10-2000)
    “…We report about a 28-year-old woman with relapsed mantle cell lymphoma (MCL, centrocytic lymphoma according to the Kiel classification) refractory to salvage…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Clinical Presentation of Non-Hodgkin Lymphomas of the Major Salivary Glands by Jaehne, J. Ußmüller, K. T. Jäkel, R. Zschaber, M.

    Published in Acta oto-laryngologica (2001)
    “…The aim of this study was to examine the clinical presentation of patients with malignant lymphoma of the major salivary glands. In a retrospective study, 26…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome by Meissner, K, Löning, T, Heckmayr, M, Zschaber, R, Jänner, M

    “…Using an immunoperoxidase (skin biopsy) and an immunofluorescence (peripheral blood, bone marrow punctate) technique, and monoclonal antibodies raised against…”
    Get full text
    Journal Article
  9. 9

    Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) by Weh, H J, Zschaber, R, Hossfeld, D K

    Published in Blut (01-04-1984)
    “…Ten AML- and two MDS-patients in whom conventional chemotherapy was contraindicated or ineffective were treated with low dose ARA-C, 10 mg/m2 per 12hS.C. for…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience by Tuinmann, Gert, Hegewisch-Becker, Susanna, Zschaber, Reinhart, Kehr, Andreas, Schulz, Juliane, Hossfeld, Dieter K

    Published in Anti-cancer drugs (01-07-2004)
    “…Despite chemotherapy, median survival of patients with advanced pancreatic cancer (APC) remains poor. Gemcitabine (GEM) remains standard treatment. Numerous…”
    Get full text
    Journal Article
  12. 12

    A subtype of the prototypic karyotype in acute myeloid leukemia t (8; 21) (q22; q22), del 9 (q13; q23) by Hossfeld, D K, Higi, M, Köhler, S, Miller, A, Zschaber, R

    Published in Blut (01-01-1980)
    “…Two patients with acute myeloid leukemia are described in whom G- and C-banding analysis of bone marrow cells revealed, besides the translocation t(8;21), an…”
    Get full text
    Journal Article
  13. 13

    Clinical presentation, therapy and prognosis of non-Hodgkin lymphomas of the major salivary glands by Jaehne, M, Ussmüller, J, Jäkel, K T, Zschaber, R

    Published in Laryngo- rhino- otologie (01-12-2001)
    “…About 5 - 10 % of all Non-Hodgkin-Lymphomas (NHL) present within the major salivary glands. Two etio-pathologically different groups, the…”
    Get more information
    Journal Article
  14. 14

    Therapeutic possibilities and demands on radiology from the internist-oncologist viewpoint in liver and pancreatic tumors by Zschaber, R

    Published in Röntgenblätter (01-09-1989)
    “…For most cases of malignant tumours of the liver and pancreas there is no cure. That is why the diagnosis should be made using a minimum of technical…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Dose-finding study for hyperfractionated, accelerated radiotherapy plus simultaneous carboplatin administration in patients with locoregionally advanced head and neck cancer by Kehrl, W, Brockmann, W P, Zschaber, R, Hartwein, J

    Published in Laryngo- rhino- otologie (01-07-1992)
    “…Therapy of large inoperable squamous cell-carcinomas of the head and neck is considerably problemful. Combined simultaneous radio-chemotherapy with carboplatin…”
    Get more information
    Journal Article
  17. 17

    Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer by GATZEMEIER, U, HECKMAYR, M, HOSSFELD, D. K, ZSCHABER, R, ACHTERRATH, W, LENAZ, L

    Published in Cancer chemotherapy and pharmacology (01-01-1990)
    “…A total of 51 previously untreated patients with non-small-cell lung cancer (NSCLC) were treated with 130 mg/m2 carboplatin given every 4 weeks as an i.v…”
    Get full text
    Journal Article
  18. 18

    Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study by Heckmayr, M, Gatzemeier, U, Hossfeld, D K, Koschel, G, Thies, F, Zschaber, R

    Published in Pneumologie (Stuttgart, Germany) (01-02-1990)
    “…Within the framework of a multi-centre prospective randomised therapeutic trial, 150 patients with small-cell lung cancer (SCLC) were treated with…”
    Get more information
    Journal Article
  19. 19

    Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide by Gatzemeier, U, Achterrath, W, Heckmayr, M, Hossfeld, D K, Neuhauss, R, Reck, M, Zschaber, R

    Published in Pneumologie (Stuttgart, Germany) (01-02-1990)
    “…In a phase II study, the combination of the new platinum derivative carboplatin with vincristine and etoposide is associated with a remission rate of 81.8 per…”
    Get more information
    Journal Article
  20. 20